CN1175825C - Medicinal composition for curing common cold - Google Patents
Medicinal composition for curing common cold Download PDFInfo
- Publication number
- CN1175825C CN1175825C CNB031306233A CN03130623A CN1175825C CN 1175825 C CN1175825 C CN 1175825C CN B031306233 A CNB031306233 A CN B031306233A CN 03130623 A CN03130623 A CN 03130623A CN 1175825 C CN1175825 C CN 1175825C
- Authority
- CN
- China
- Prior art keywords
- medicine
- parts
- compound
- common cold
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a medicinal composition for curing common cold. In the prior art, medicine for curing common cold has western medicine, such as compound aspirin, compound paracetamol, compound ammonia phenol dextromethorphan, etc., and traditional Chinese medicine, such as compound isatis root, compound double blossom, antelope horn and forsythia toxin-resolving pills, etc., wherein western medicine has the characteristics of quick effect and high adverse reaction rate; traditional Chinese medicine has the characteristics of soft action, low adverse reaction rate and slow effect. The present invention selects paracetamol, caffeine, chlorpheniramine maleate, antelope horn powder and artificial bezoar to prepare the medicine for curing common cold, and greatly reduces the doses of the three kinds of western medicine and toxic and side effect thereof. The present invention not only reserves the characteristics of quick action and exact curative effect of western medicine, but also reduces adverse reaction rate to enhance the action of traditional Chinese medicine. Thereby, the present invention is favorable to increase the common cold resistance of organisms.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of flu, particularly a kind of pharmaceutical composition for the treatment of flu.
Background technology
In the prior art, the medicine of treatment flu has Western medicine, as aspirin compound, Aminodyne Compound, Compond Paracetanol and Dextromethorphan etc., Chinese medicine is arranged also, sticks up detoxifying pills etc. as compound isatic root, compound recipe Flos Lonicerae, antelope.The characteristics of Western medicine are instant effects, but untoward reaction rate height, the characteristics of Chinese medicine are that effect is gentle, the untoward reaction rate is low, but it is slower to take effect.Therefore, if in Western medicine, add Chinese medicinal ingredients, can be in conjunction with the advantage of Chinese medicine and western medicine, obtain treatment flu instant effect, effect that the untoward reaction rate is low.
Summary of the invention
The objective of the invention is to overcome the deficiency of existing coldrex, a kind of determined curative effect, instant effect, coldrex that the untoward reaction rate is low are provided.
The pharmaceutical composition of treatment flu of the present invention is selected acetaminophen, caffeine, chlorphenamine maleate, Cornu Saigae Tataricae powder and artificial Calculus Bovis, promptly increases Cornu Saigae Tataricae powder on the basis of metho kahuangmin sheet.Wherein, acetaminophen has the effect of antipyretic-antalgic, is the less kind of untoward reaction in the Western medicine, serious side effects such as that consumption too much still can produce is nauseating, vomiting, stomachache, liver and kidney failure, cerebral edema; Caffeine can act on the high-order maincenter of cerebral cortex, promotes mental excitation, and the fatigue that excuse is generated heat bitterly and caused is removed in the drowsiness side effect of opposing chlorphenamine maleate simultaneously, problems such as consumption too much can cause nausea, has a headache, insomnia; Chlorphenamine maleate is an antihistaminic, the effect of competitive blocking-up amine receptor, can alleviate, alleviate sneeze, shed tears, cold symptoms such as watery nasal discharge and throat itch, but that consumption too much can cause is drowsiness, uncomfortable in chest, cardiopalmus, dizziness etc., Cornu Saigae Tataricae has suppressing the hyperactive liver to relieve the wind syndrome, liver heat removing and eyesight improving, the effect of the blood detoxifcation of loosing, be usually used in hyperpyrexia infantile convulsion, coma convulsion faint, have a headache dazzle the eyes, the conjunctival congestion cataracta; Calculus Bovis have clear away heart-fire, eliminating phlegm, have one's ideas straightened out, the function of detoxifcation, be usually used in calentura coma, laryngopharynx swelling and pain.Among the present invention, Cornu Saigae Tataricae powder and acetaminophen, caffeine, chlorphenamine maleate and artificial Calculus Bovis are collaborative mutually, have accelerated curative effect.
Through a large amount of experiments, the composition of pharmaceutical composition of the present invention is that following weight parts can obtain tangible curative effect: 100～500 parts of acetaminophen, 5～20 parts of caffeine, 1～3 part of chlorphenamine maleate, 2～6 parts of Cornu Saigae Tataricae powders, 5～15 parts of artificial Calculus Boviss.
Be preferably: 200～300 parts of acetaminophen, 10～20 parts of caffeine, 1.5～2.5 parts of chlorphenamine maleate, 3～5 parts of Cornu Saigae Tataricae powders, 8～12 parts of artificial Calculus Boviss.
Best proportioning is: 250 parts of acetaminophen, 15 parts of caffeine, 2 parts of chlorphenamine maleate, 4 parts of Cornu Saigae Tataricae powders, 10 parts of artificial Calculus Boviss.
Advantage of the present invention is: adopt the Chinese medicine and western medicine combination, Western medicine determined curative effect, characteristics are fast promptly arranged, reduced its side effect again.
The specific embodiment
Below further illustrate the beneficial effect of medicine of the present invention by clinical trial.
One, clinical data
1. medical record situation: in 1421 parts of flu medical records in 2002, use the present invention to treat 938 of the medical records of the pharmaceutical composition (calling quick of the yellow ammonia coffee of antelope in the following text) of flu, use 483 of the medical records of metho kahuangmin sheet.Randomly drawing 120 samples respectively from above-mentioned two groups of medical records adds up;
2. the prescription of quick of the yellow ammonia coffee of antelope is: 1. group: acetaminophen 110mg, caffeine 5.5mg, chlorphenamine maleate 1mg, Cornu Saigae Tataricae powder 2.5mg, artificial Calculus Bovis 6mg; 2. organize: acetaminophen 250mg, caffeine 15mg, chlorphenamine maleate 2mg, Cornu Saigae Tataricae powder 4mg, artificial Calculus Bovis 10mg; 3. organize: acetaminophen 250mg, caffeine 15mg, chlorphenamine maleate 2mg, Cornu Saigae Tataricae powder 4mg, artificial Calculus Bovis 10mg;
3. sample situation:
In 120 cases, anemofrigid cold 61 examples (male 27 examples, women 34 examples, age 20-72 year, average 34.0 years old) wherein, anemopyretic cold 59 examples (male 26 examples, women 33 examples, age 15-56 year, average 30.7 years old).Tcm diagnosis is flu, and Western medicine diagnose is a upper respiratory tract infection, and the Shi Junyou that sees and treat patients heating (37.0 ℃～39.5 ℃ of body temperature), headache symptom partly have symptoms such as cough, dry pharynx, nasal obstruction, laryngalgia, watery nasal discharge; The rhythm of the heart is breathed all normal, and partly the hemogram leukocyte raises; White and thin fur, red tongue, floating and rapid pulse appear in majority.At random aforementioned 120 cases are divided into its 3 groups of A, B and C, every group of each 40 example.
Two, Therapeutic Method
Quick of A, B and the yellow ammonia coffee of respectively oral 1., the 2. and 3. antelope of C group, 3 times on the one, were taken medicine 3 days continuously by 2 slices/time.
Three, therapeutic effect
1. criterion of therapeutical effect:
Recovery from illness: heating, headache, dizziness, cough, dry pharynx, nasal obstruction, laryngalgia, all transference cures of watery nasal discharge;
Be clearly better: body temperature is normal, and headache, cough, nasal obstruction, all diseases of laryngalgia obviously alleviate;
Sx: body temperature＜37 ℃, no headache, nasal obstruction symptom, other symptom obviously alleviates.
2. therapeutic effect is tabulated
In secular clinical observation, do not find this product is had the case of untoward reaction, therefore, in normal dose, take, the present invention is safe.
3. model case:
Wang Shufen, woman, 37 years old.Internal medicine is anxious precious; The main suit: after suffering from cold last evening, self-induction fever with aversion to cold, headache, dizziness, pharyngalgia, limbs pain; Survey 39.5 ℃ of body temperature, look into red swelling of the pharynx, no pus point, red tongue, white and moist fur, floating and rapid pulse, hemogram WBC14.6 * 10
9/ L; Be diagnosed as anemofrigid cold.Quick of the yellow ammonia coffee of oral antelope, 3 times on the one, serve on 2 days by 2 slices/time.Further consultation: 36.5 ℃ of body temperature, hemogram WBC9.0 * 10
9/ L.Headache, dizzy transference cure, pharyngalgia alleviates.
Claims (3)
1. pharmaceutical composition for the treatment of flu, it is characterized in that: comprise acetaminophen, caffeine, chlorphenamine maleate, Cornu Saigae Tataricae powder and artificial Calculus Bovis, the weight proportion of above each component is:
100～500 parts of acetaminophen, 5～20 parts of caffeine, 1～3 part of chlorphenamine maleate, 2～6 parts of Cornu Saigae Tataricae powders, 5～15 parts of artificial Calculus Boviss.
2. the pharmaceutical composition of treatment flu as claimed in claim 1, it is characterized in that: the weight proportion of each component is:
200～300 parts of acetaminophen, 10～20 parts of caffeine, 1.5～2.5 parts of chlorphenamine maleate, 3～5 parts of Cornu Saigae Tataricae powders, 8～12 parts of artificial Calculus Boviss.
3. the pharmaceutical composition of treatment flu as claimed in claim 1, it is characterized in that: the weight proportion of each component is:
250 parts of acetaminophen, 15 parts of caffeine, 2 parts of chlorphenamine maleate, 4 parts of Cornu Saigae Tataricae powders, 10 parts of artificial Calculus Boviss.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031306233A CN1175825C (en) | 2003-05-06 | 2003-05-06 | Medicinal composition for curing common cold |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031306233A CN1175825C (en) | 2003-05-06 | 2003-05-06 | Medicinal composition for curing common cold |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1457801A CN1457801A (en) | 2003-11-26 |
| CN1175825C true CN1175825C (en) | 2004-11-17 |
Family
ID=29430536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB031306233A Expired - Fee Related CN1175825C (en) | 2003-05-06 | 2003-05-06 | Medicinal composition for curing common cold |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1175825C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1314399C (en) * | 2004-11-26 | 2007-05-09 | 贵阳高新瑞得科技开发有限公司 | Child metho kahuangmin effervescent granules and its making method |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100386071C (en) * | 2005-06-22 | 2008-05-07 | 叶耀良 | Medicine for treating cough and chronic bronchitis |
| CN109464363A (en) * | 2018-11-30 | 2019-03-15 | 江苏贝塔仕生物科技有限公司 | A kind of formula of novel face washing milk |
-
2003
- 2003-05-06 CN CNB031306233A patent/CN1175825C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1314399C (en) * | 2004-11-26 | 2007-05-09 | 贵阳高新瑞得科技开发有限公司 | Child metho kahuangmin effervescent granules and its making method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1457801A (en) | 2003-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101364803B1 (en) | Pharmaceutical composition containing EPHEDRAE HERBA for treating bronchitis and preparation method thereof | |
| CN1210047C (en) | Medicine for treating cold and preparation method thereof | |
| CN102366595A (en) | Medicine for treating diabetes and preparation method thereof | |
| CN104857435B (en) | A kind of Traditional Chinese medicine compound composition with antitumor activity and its preparation method and application | |
| CN1175825C (en) | Medicinal composition for curing common cold | |
| CN104435648B (en) | A kind of composition of food and medicament dual-purpose and application thereof and preparation method | |
| CN106177276A (en) | Alleviate asthenopic collyrium and preparation method thereof | |
| CN102552677B (en) | Coptis chinensis and radix rehmanniae Anxiao capsule and preparation method thereof | |
| CN1233364C (en) | Chinese medicine for treating digestive ulcerating sore and its preparation method | |
| CN100345587C (en) | Medicine for treating aural dizziness and cervical dizziness and its prepn process | |
| CN1490043A (en) | Medicine for resolving sputum and relieving asthma and cough, preparing process thereof | |
| CN105687499A (en) | Betaxolol containing pharmaceutical composition for treating hypertension and preparation method thereof | |
| CN102366540A (en) | Medicine for treating diabetes and its preparation method | |
| CN106110029A (en) | A kind of external-applied ointment treating skin allergy and preparation method | |
| CN100409884C (en) | Chinese traditional medicine for treating cold | |
| CN105106855A (en) | Traditional Chinese medicine preparation for treating apoplexy sequela | |
| CN103893308B (en) | Hot-compress Chinese medicine ointment for treating abdominal pain and preparation method thereof | |
| CN114939149A (en) | Composition for clearing heat from throat and relieving physical fatigue and application thereof | |
| CN101032576A (en) | Impotence-treating Chinese traditional medicine prepn. and its prepn. process | |
| CN111544500A (en) | Traditional Chinese medicine composition for assisting blood pressure reduction and external preparation and application thereof | |
| CN1238048C (en) | Chinese traditional medicine for treating arthralgia syndrome and its preparation | |
| CN106492042A (en) | A kind of Chinese medicine composition for treating toothache | |
| CN100482251C (en) | Chinese medicinal formulation for curing hypertension by treating disease cause | |
| CN101890098B (en) | Medicament for treating type II diabetic cardiopathy and preparation method thereof | |
| CN102949470A (en) | Traditional Chinese medicine dispersible tablet for treating headache and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20041117 |